772 related articles for article (PubMed ID: 15712176)
21. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
22. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
Kovrigina AM; Probatova NA
Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
[TBL] [Abstract][Full Text] [Related]
23. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
24. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
25. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
26. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
27. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
28. T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines.
Jöhrens K; Stein H; Anagnostopoulos I
Am J Surg Pathol; 2007 Aug; 31(8):1181-5. PubMed ID: 17667540
[TBL] [Abstract][Full Text] [Related]
29. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
30. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
31. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
32. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
33. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
[TBL] [Abstract][Full Text] [Related]
34. Loss of CD19 expression in B-cell neoplasms.
Masir N; Marafioti T; Jones M; Natkunam Y; Rüdiger T; Hansmann ML; Mason DY
Histopathology; 2006 Feb; 48(3):239-46. PubMed ID: 16430470
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
[TBL] [Abstract][Full Text] [Related]
36. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
37. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
38. [Pathology of Hodgkin's lymphoma].
Hansmann ML; Willenbrock K
Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
[TBL] [Abstract][Full Text] [Related]
39. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
40. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
